Aktis Oncology, Inc. ($AKTS)
Filing Information
| Accession Number | 0001473930-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 14, 2026 |
| Document Date | Jan 12, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
19,462,676
Total Value
$4,191,660.00
P&L
+8.3% (+$349,305.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 12, 2026 | Conversion | 597,391 | โ | โ | 597,391 | Indirect | See Footnote | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Conversion | 2,688,270 | โ | โ | 3,285,661 | Indirect | See Footnote | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Conversion | 716,872 | โ | โ | 4,002,533 | Indirect | See Footnote | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Purchase | 232,870 | $18.00 | $4,191,660.00 | 4,235,403 | Indirect | See Footnote | View Details | |
Director | Series Seed Redeemable Convertible Preferred Stock | Derivative | Jan 12, 2026 | Conversion | 2,272,727 | $0.00 | $0.00 | 0 | Indirect | See Footnote | View Details | |
Director | Series A Redeemable Convertible Preferred Stock | Derivative | Jan 12, 2026 | Conversion | 10,227,273 | $0.00 | $0.00 | 0 | Indirect | See Footnote | View Details | |
Director | Series B Redeemable Convertible Preferred Stock | Derivative | Jan 12, 2026 | Conversion | 2,727,273 | $0.00 | $0.00 | 0 | Indirect | See Footnote | View Details |